Drugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.
Pfizer said Friday that the Food and Drug Administration has approved a new nasal spray to treat migraines.
Zavzpret, a branded formulation of the generic drug zavegepant, is the"first and only" calcitonin gene-related peptide receptor antagonist nasal spray for treating migraines with or without an aura, or sensory disturbances such as flashes ofZavzpret began working to treat migraine symptoms in as little as 30 minutes and provided some relief for up to 48 hours after the last administered dose, Pfizer said, citing a...
published in The Lancet. A 10mg dose of the drug proved more effective than a placebo at relieving pain and other migraine symptoms, the study found.Angela Hwang, chief commercial officer and president of Pfizer's global biopharmaceuticals business, said in a statement that Zavzpret provides another option for the many people who suffer migraines.
Migraines are moderate or severe headaches that can cause a throbbing pain usually occurring on just one side of the head, according to. Other symptoms may include nausea, vomiting, and sensitivity to light and sound. Migraines affect more than 10% of people globally, with people between the ages of 20 and 50 most likely to experience the condition, according to
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA approves Pfizer's new nasal spray treatment for migrainesThe FDA approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant), the first and only migraine treatment offered in a nasal spray.
Consulte Mais informação »
Pfizer wins FDA approval for its migraine nasal sprayPfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
Consulte Mais informação »
US FDA approves Pfizer's pain-relief nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Consulte Mais informação »
US FDA approves Pfizer's nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Consulte Mais informação »
FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | CNNThe FDA has approved a new nasal spray as a rapid treatment for migraine pain in adults. The spray may relieve pain and other migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer says.
Consulte Mais informação »
FDA Approves Amphastar Pharma's Nasal Spray for Opioid OverdoseAmphastar Pharmaceuticals Inc said on Wednesday the FDA had approved its nasal spray for emergency treatment of known or suspected opioid overdose.
Consulte Mais informação »